Ex Parte Harvey et alDownload PDFPatent Trial and Appeal BoardMar 30, 201511348898 (P.T.A.B. Mar. 30, 2015) Copy Citation UNITED STATES PATENT AND TRADEMARK OFFICE UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 11/348,898 02/06/2006 Michael S. Harvey 8568/13290 8056 7590 03/30/2015 Audrey A. Millemann Weintraub Genshlea Chediak 11th Floor 400 Capitol Mall Sacramento, CA 95814 EXAMINER GEORGE, PATRICIA ANN ART UNIT PAPER NUMBER 1793 MAIL DATE DELIVERY MODE 03/30/2015 PAPER Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE ____________ BEFORE THE PATENT TRIAL AND APPEAL BOARD ____________ Ex parte MICHAEL S. HARVEY and JONATHAN N. HOWARTH ____________ Appeal 2013-002697 Application 11/348,898 Technology Center 1700 ____________ Before CHUNG K. PAK, CHARLES F. WARREN, and JEFFREY T. SMITH, Administrative Patent Judges. Opinion for the Board by SMITH, Administrative Patent Judge. Opinion dissenting by PAK, Administrative Patent Judge. DECISION ON APPEAL STATEMENT OF THE CASE This is an appeal under 35 U.S.C. § 134(a) from a final rejection of claims 1, 2, 4, and 5. We have jurisdiction under 35 U.S.C. § 6. The Examiner maintains the following § 103 rejections: Claims 1 and 2 are rejected under 35 U.S.C. § 103(a) over Oakes (US 5,200,189, issued Apr. 6, 1993) in view of Shin, J.H., Application of antimicrobial ice for reduction of foodborne pathogens (Escherichia coli O157:H7, Salmonella Typhimurium, Listeria monocytogenes) on the surface of fish, Journal of Applied Microbiology, Volume 97, Issue 5, pp. 916–922 (2004), and Cosentino (US 5,508,046, issued Apr. 16, 1996). Appeal 2013-002697 Application 11/348,898 2 Claims 4 and 5 are rejected under 35 U.S.C. § 103(a) over Oakes in view of Shin, Cosentino, and Roberts (US 2,949,019, issued Aug. 16, 1960). A complete statement of the appealed rejection appears in the Final Office Action mailed July 19, 2011. Appellants’ invention relates to compositions and methods to prevent spoilage and microbial contamination of perishable foods. (Spec. 1). Claim 1 is representative of the subject matter on appeal and is reproduced below: 1. A frozen antimicrobial composition for use in reducing microbial contamination and spoilage of a perishable food product, comprising a peroxycarboxylic acid, hydrogen peroxide, and water, wherein said composition contains about 2 to about 200 ppm of the peroxycarboxylic acid and about 10 to about 1000 ppm of the hydrogen peroxide. After review of the arguments presented by Appellants in the Brief and the responses presented by the Examiner in the Final Office Action and the Answer, we affirm the appealed rejections. We add the following. 1 Appellants argue Oakes teaches away from the claimed invention because Oakes’ composition comprising peroxycarboxylic acid, hydrogen peroxide, and water is intended to be a solution to be used for cleaning equipment and Oakes provides no advantage or reason to freeze the composition. (Br. 11). Appellants also rely on the Declaration of Jonathan 1 In addressing the rejections, Appellants’ arguments for patentability are principally directed to independent claim 1. Br. 9–16. Appellants have not presented substantive arguments directed to the remaining claims. Id. We select independent claim 1 as representative and will limit our discussion to this claim. Appeal 2013-002697 Application 11/348,898 3 N. Howarth 2 of record to support their arguments for patentability of the claimed subject matter. (Br. 10–11). Oakes describes compositions containing biocidally active (antimicrobial) components that are used to sterilize surfaces intended to contact food products. Oakes teaches the antimicrobial composition is capable of being diluted with water to form sanitizing solutions. (Oakes, col. 2, ll. 33–37). Oakes teaches aqueous compositions comprising peroxycarboxylic acid and hydrogen peroxide as biocidally active components. Oakes discloses the antimicrobial components are used in amounts that are suitable for surfaces in contact with food products. (Oakes, col. 1, ll. 43–53). Shin teaches it was known to form frozen compositions (ice) containing an antimicrobial component (chlorine dioxide) to reduce pathogens on the surface of fish. (Shin, Abstract). The problem of bacterial spoilage of perishable food products caused by a variety of microbes was recognized by persons of ordinary skill in the art at the time of the invention. (Shin; Spec. 1). According to the Specification, “[c]hemical intervention measures and low temperature processing are also routinely practiced in the meat and poultry industries in an attempt to control the growth of pathogenic or decay-causing microorganisms.” (Spec. 2). Concerns for controlling the bacterial spoilage of perishable food products include human health and financial repercussions. (Spec. 3). An ice containing biocidally active components has been commonly or conventionally used to prevent spoilage and 2 Filed on March 10, 2010. Appeal 2013-002697 Application 11/348,898 4 pathogenic microorganism growth on food products. (Spec. 4). The specification specifically states: Several attempts have been made to delay the onset of the naturally occurring decomposition processes that occur in perishable foods that are commonly packed on ice. Most of these attempts include incorporating a biocidally active composition or additive into water used to make ice. This ice is sometimes referred to as a frozen biocidally-active composition. During storage and transportation, as the ice melts, the biocide is released to provide efficacy against spoilage and pathogenic microorganisms still remaining on the food. (Spec. 4). The use of water and ice compositions containing chlorine dioxide (a biocidally active component) in contact with food products has been restricted by the FDA due to toxicological concerns. (Spec. 5). Other failed techniques to prevent spoilage include the incorporation of silver- impregnation zeolites as a biocidally active component in ice compositions. (Spec. 6). In other words, Appellants acknowledge 3 and Shin teaches that the use of biocidally active containing compositions to reduce and prevent spoilage and pathogenic microorganisms growth on food was known to those of ordinary skill in the art. These biocidally active compositions are composed of biocidally active containing components ingredients which are 3 It is axiomatic that admitted prior art in an applicants’ specification may be used in determining the patentability of a claimed invention. (In re Nomiya, 509 F.2d 566, 570–71 (CCPA 1975)); and that consideration of the prior art cited by the Examiner may include consideration of the prior art found in applicants’ specification. (In re Davis, 305 F.2d 501, 503 (CCPA 1962); cf., In re Hedges, 783 F.2d 1038, 1039–40 (Fed. Cir. 1986)). Appeal 2013-002697 Application 11/348,898 5 known to be assessed for their acceptable for the use on foods. 4 Thus, we determine that one of ordinary skill in the art is imputed with knowledge regarding the suitability of forming compositions containing biocidally active components to prevent spoilage and pathogenic microorganisms growth on food which are not harmful to humans. In determining obviousness under 35 U.S.C. § 103, the relevant inquiry is “whether the person of ordinary skill in the art, possessed with the understandings and knowledge reflected in the prior art, and motivated by the general problem facing the inventor, would have been led to make the combination recited in the claims.” In re Kahn, 441 F.3d 977, 988 (Fed. Cir. 2006). A person of ordinary skill in the art concerned with the toxicological contamination of food products would have sufficient skilled to determine suitable antimicrobial components for use in frozen biocidally active compositions. Oakes describes known antimicrobial components that are suitable for use in aqueous solutions. A person of ordinary skill in the art would have reasonably expected that these antimicrobial components when contained in a frozen composition would function as the composition melts. We have considered the Declaration of the inventor, but do not find it persuasive of establishing patentability of the appealed subject matter. Although factual evidence is preferable to opinion testimony, such testimony is entitled to consideration and some weight so long as the opinion is not on the ultimate legal conclusion at issue. While an opinion as to a legal conclusion is not entitled to any weight, the underlying basis for the opinion may be persuasive. In re Chilowsky, 306 F.2d 908, 916 (CCPA 1962) 4 See the above discussed Description of the Related Art section of the Specification. Appeal 2013-002697 Application 11/348,898 6 (expert opinion that an application meets the requirements of 35 U.S.C. § 112 is not entitled to any weight; however, facts supporting a basis for deciding that the specification complies with 35 U.S.C. § 112 are entitled to some weight); In re Lindell, 385 F.2d 453, 456 (CCPA 1967). On this record, Declarant has not directed us to evidence that establishes a person of ordinary skill in the art would not have recognized the suitability of incorporating antimicrobial components in frozen compositions. Appellants, in the Briefs, have not directed us to evidence of unexpected results in rebuttal to the appealed rejection. Accordingly, we affirm the Examiner’s obviousness rejection of claims 1, 2, 4, and 5 for the reasons presented by the Examiner and given above. ORDER The Examiner’s obviousness rejection is AFFIRMED. No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a)(1). AFFIRMED UNITED STATES PATENT AND TRADEMARK OFFICE ____________ BEFORE THE PATENT TRIAL AND APPEAL BOARD ____________ Ex parte MICHAEL S. HARVEY and JONATHAN N. HOWARTH ____________ Appeal 2013-002697 Application 11/348,898 Technology Center 1700 ____________ Pak, Administrative Patent Judge, Dissenting Because the Examiner has not demonstrated that one of ordinary skill in the art would have been led to freeze Oak’s sanitizing solutions comprising peroxycarboxylic acid, hydrogen peroxide, and water to form a frozen composition containing the same, I dissent from the affirmance of the Examiner’s obviousness rejections set forth in the Answer. As is apparent from the majority’s discussion supra, the Examiner has relied upon known compositions containing an antimicrobial component (chlorine dioxide) used in the form of an ice (frozen form), as taught by Shin, to reduce pathogens on the surface of fish as a reason to freeze Oak’s sanitizing solutions in the form of an ice. However, the Examiner has not shown that Oak’s sanitizing solutions are not toxic and are suitable for food. Nor has the Examiner shown that there is any other reason for freezing Oak’s sanitizing solutions in the form of an ice. Appeal 2013-002697 Application 11/348,898 2 The majority also relies on information in the Specification as admitted prior art in affirming the Examiner’s obviousness rejections set forth in the Answer. According to the majority, biocidally active compositions composed of biocidally active components, inclusive of Oak’s sanitizing solutions containing biocidally active components, were known to be assessed for their acceptability for the use on foods, thus imparting some reason or suggestion to form Oak’s sanitizing solutions in the form of an ice upon determining their acceptability for use in the food through routine experimentation. However, Appellants have not unequivocally or clearly stated in the Specification that such information was known in the art despite the fact that Appellants have the duty to disclose the prior art status of such material information if such information is, in fact, prior art. Accordingly, based on the reasons set forth in the Appeal Brief and above, I would reverse the Examiner’s decision rejecting the claims on appeal under 35 U.S.C. §103(a). kmm Copy with citationCopy as parenthetical citation